View by Specialty

Headline News

View more

Inhaled insulin lowers HbA1c at 30 weeks in adults with type 1 diabetes

March 21, 2025
4 min read
Save

Inhaled insulin lowers HbA1c at 30 weeks in adults with type 1 diabetes

Inhaled insulin lowers HbA1c at 30 weeks in adults with type 1 diabetes

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c at 30 weeks for adults with type 1 diabetes, according to findings from the INHALE-3 extension trial.

View more Headline News
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails

Resources

View more

AI in Medicine

Psychedelics & Alternative Therapies

View more Resources
View more Meeting News
View meeting calendar

Blogs & Columns

View more
Saleh Aldasouqi

Endocrinology Blog

with Saleh Aldasouqi, MD, FACE, ECNU
In his “From the Doctor’s Bag” blog, Saleh Aldasouqi, MD, FACE, ECNU, takes a lighthearted look at issues at the intersection of the humanities and medicine.
Jonathan Leffert

Putting It Into Practice

with Jonathan D. Leffert, MD, FACP, FACE, ECNU
Jonathan D. Leffert, MD, FACP, FACE, ECNU, speaks with experts about best advice and strategies for a healthy endocrine practice.
View more Blogs & Columns